Skip to content
Trial Eligibility
Menu

Ventilation and Perfusion in Asthmatics

NCT07426458

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

Assess regional changes to perfusion and ventilation from inhaled corticosteroid (ICS) and Fast-acting beta-antagonist (FABA) among adult asthmatics using radiographically derived estimates of regional ventilation (V-distribution), ventilation defect percentage (VDP), and ventilation heterogeneity (VH).

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Asthma

Eligibility basics and study details

Study type
Interventional
Phase
Phase 4
Ages
18 to 75 years
Sex
All
Healthy volunteers
Not accepted
Sponsor
University of Miami
Last updated on ClinicalTrials.gov
May 5, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Florida · 1

  • University of Miami - Converge Miami · Miami, FL

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.